Serial Recombineering Cloning to Build Selectable and Tagged Genomic P[acman] BAC Clones for Selection Transgenesis and Functional Gene Analysis using Drosophila melanogaster
Current Protocols · 2023
DOI: 10.1002/cpz1.675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols, 2023. Verfasst von Koen J T Venken und 3 weiteren Autor:innen. Beteiligte Einrichtung: Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas. Hauptthemen laut MEDLINE: Drosophila melanogaster, Gene Transfer Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIMH NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Transgenes with genomic DNA fragments that encompass genes of interest are the gold standard for complementing null alleles in rescue experiments in the fruit fly Drosophila melanogaster . Of particular interest are genomic DNA clones available as bacterial artificial chromosomes (BACs) or fosmids from publicly available genomic DNA libraries. Genes contained within BAC and fosmid clones can be easily modified by recombineering cloning to insert peptide or protein tags to localize, visualize, or manipulate gene products, and to create point mutations or deletions for structure‐function analysis of the inserted genes. However, since transgenesis efficiency is inversely correlated with transgene size, obtaining transgenic animals for increasingly larger BAC and fosmid clones requires increasingly laborious screening efforts using the transgenesis marker commonly used for these transgenes, the dominant eye color marker white + . We recently described a drug‐based selectable genetic platform for Drosophila melanogaster , which included four resistance markers that allow direct selection of transgenic animals, eliminating the need to identify transgenic progeny by laborious phenotypic screening. By integrating these resistance markers into BAC transgenes, we were able to isolate animals containing large transgenes by direct selection, avoiding laborious screening. Here we present procedures on how to upgrade BAC clones by serial recombineering cloning to build both selectable and tagged BAC transgenes, for selection transgenesis and functional gene analysis, respectively. We illustrate these procedures using a BAC clone encompassing the gene encoding the synaptic vesicle protein, cysteine string protein. We demonstrate that the modified BAC clone, serially recombineered with a selectable marker for selection transgenesis and an N‐terminal green fluorescent protein tag for gene expression analysis, is functional by showing the expression pattern obtained after successful selection transgenesis. The protocols cover: (1) cloning and preparation of the recombineering templates needed for serial recombineering cloning to incorporate selectable markers and protein tags; (2) preparing electrocompetent cells needed to perform serial recombineering cloning; and (3) the serial recombineering workflow to generate both selectable and tagged genomic BAC reporter transgenes for selection transgenesis and functional gene analysis in Drosophila melanogaster . The protocols we describe can be easily adapted to incorporate any of four selectable markers, protein tags, or any other modification for structure‐function analysis of the genes present within any of the BAC or fosmid clones. A protocol for generating transgenic animals using serially recombineered BAC clones is presented in an accompanying Current Protocols article (Venken, Matinyan, Gonzalez, & Dierick, 2023a). © 2023 Wiley Periodicals LLC. Basic Protocol 1 : Cloning and preparation of recombineering templates used for serial recombineering cloning. Basic Protocol 2 : Making electrocompetent cells of the bacterial strains used to perform serial recombineering cloning or induction of plasmid copy number. Basic Protocol 3 : Serial recombineering cloning to generate both selectable and tagged genomic P[acman] BAC reporter transgenes for selection transgenesis and gene expression analysis in Drosophila melanogaster .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas.
- Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas.
- Integrative Molecular Biomedical Sciences Graduate Program, Baylor College of Medicine, Houston, Texas.
- McNair Medical Institute at The Robert and Janice McNair Foundation, Baylor College of Medicine, Houston, Texas.
- Present address: Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
Förderung
- NIH HHS
- NIMH NIH HHS
- NHGRI NIH HHS
- NIGMS NIH HHS
- Foundation for Angelman Syndrome Therapeutics
- Cancer Prevention and Research Institute of Texas
- National Institutes of Health
- Baylor College of Medicine
Zitieren
APA
Venken, K. J. T., Matinyan, N., Gonzalez, Y., & Dierick, H. A. (2023). Serial Recombineering Cloning to Build Selectable and Tagged Genomic P[acman] BAC Clones for Selection Transgenesis and Functional Gene Analysis using Drosophila melanogaster. Current Protocols. https://doi.org/10.1002/cpz1.675
Vancouver
Venken KJT, Matinyan N, Gonzalez Y, Dierick HA. Serial Recombineering Cloning to Build Selectable and Tagged Genomic P[acman] BAC Clones for Selection Transgenesis and Functional Gene Analysis using Drosophila melanogaster. Current Protocols. 2023. doi:10.1002/cpz1.675
BibTeX
@article{Venken2023,
author = {Venken, Koen J T and Matinyan, Nick and Gonzalez, Yezabel and Dierick, Herman A},
title = {Serial Recombineering Cloning to Build Selectable and Tagged Genomic P[acman] BAC Clones for Selection Transgenesis and Functional Gene Analysis using Drosophila melanogaster},
journal = {Current Protocols},
year = {2023},
doi = {10.1002/cpz1.675}
}
EUVIMED